Location History:
- Aschaffenburg, DE (2005)
- Taufkirchen, DE (2010 - 2014)
Company Filing History:
Years Active: 2005-2014
Title: Innovations by Inventor Arne Gehlen
Introduction
Arne Gehlen is a prominent inventor based in Taufkirchen, Germany, known for his significant contributions to the field of blood treatment through innovative membrane technology. With a total of four patents to his name, Gehlen has focused on developing advanced solutions for dialysis processes, addressing critical challenges in the medical industry.
Latest Patents
Gehlen's latest inventions include a dialysis membrane with improved removal of middle molecules and a high-flux dialysis membrane with enhanced separation behavior. The first patent describes a hydrophilic, semipermeable hollow-fiber membrane designed for blood treatment, featuring an integrally asymmetric structure made from synthetic polymer materials. This innovative membrane has a separating layer and an open-pored supporting layer, enabling an ultrafiltration rate in albumin solution of 5 to 25 ml/(h·m·mmHg). Notably, it is free from pore-stabilizing additives, with a maximum sieving coefficient for albumin of 0.005.
The second patent outlines a high-flux dialysis membrane that possesses similar structural characteristics but operates at an ultrafiltration rate ranging from 25 to 60 ml/(h·m·mmHg). This membrane also excludes pore-stabilizing additives and demonstrates a minimum sieving coefficient for cytochrome c of 0.8, alongside an albumin sieving coefficient of 0.005. Both patents showcase a novel method for membrane preparation using coagulation induced by a non-solvent, further advancing the technology in this critical field.
Career Highlights
Arne Gehlen has been instrumental in the research and development of advanced membrane technologies at Membrana GmbH. His work reflects a deep commitment to enhancing patient care through innovative solutions, establishing him as a key figure in medical engineering.
Collaborations
Throughout his career, Gehlen has collaborated with notable colleagues, including Friedbert Wechs and Bodo Von Harten. Their joint efforts have contributed significantly to the advancement of dialysis membrane technologies, showcasing the importance of teamwork in driving innovation.
Conclusion
Arne Gehlen has made remarkable strides in the field of blood treatment technology with his innovative membrane patents. His commitment to research and collaboration has positioned him as a leading inventor in this vital area of healthcare. Gehlen’s work continues to inspire advancements that improve the quality of life for patients requiring dialysis treatment.